Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FDHT-PET to Visualize the Effect on the Androgen Receptor Level by Bicalutamide

NCT02697032 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT02697032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02697032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FDHT-PET to Visualize the Effect on the Androgen Receptor Level by Bicalutamide
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2016
Completion date
November 25, 2019
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer